Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-08-09 00:00:00 ET · period of report 2023-08-07 · accession 0001209191-23-045215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-09 | 2023-08-07 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +200.0K | 308.3K | +185% | $0 |
| D | 2023-08-09 | 2023-08-07 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-07 | A | A | 200,000 | $0.00 | 308,261 | D | — | — | (F1) Represents the grant of Restricted Stock Units ("RSUs") that vest quarterly over 1 year from August 1, 2023, subject to the reporting person's continued service with the company on each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-08-07 | A | A | 300,000 | $0.00 | 300,000 | D | $1.77 · — to 2033-08-06 | 300,000 Common Stock | (F2) Twenty-Five percent of the shares subject to the option vest on August 7, 2024 and the remainder vest quarterly in equal installments over the following 3 years, subject to the reporting person's continued service with the company on each such date. |